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Abstract: The phosphorylated form of the high-molecular-weight neurofilament 
subunit NF-H (pNF-H) in serum or in cerebro-spinal fluid (CSF) is a specific lesional 
biomarker for spinal cord injury. The lesional biomarkers and the reaction biomarkers 
are both presented after several hours post-injury. The specific predictive patterns of 
lesional biomarkers could be used to aid clinicians with making a diagnosis and 
establishing a prognosis, and evaluating therapeutic interventions. Diagnosis, prognosis, 
and treatment guidance based on biomarker used as a predictive indicator can determine 
ethical difficulties by differentiated therapies in patients with spinal cord compression. 
At this point based on studies until today we cannot take a decision based on biomarker 
limiting the treatment of neurological recovery in patients with complete spinal cord 
injury because we do not know the complexity of the biological response to spinal cord 
compression.   
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Introduction 
Spinal compression with radicular or 
spinal cord injury is caused by inflammatory 
diseases, disk degeneration, spinal injuries or 
other causes as tumors, infections etc. The 
phosphorylated form of the high-molecular-
weight neurofilament subunit NF-H (pNF-H) 
in serum or in cerebro-spinal fluid (CSF) is a 
specific biomarker for spinal cord lesion.  
In spinal cord injury the direct mechanical 
injuries cause axonal destruction and 
destruction of the neurons and their 
destruction releases the lesional biomarkers. 
The reactions of other injured cells start 
simultaneously and the produced substances 
are the reaction biomarkers. The lesional 
biomarkers and the reaction biomarkers are 
both presented after several hours post-injury. 
A  comparison between degenerative diseases 
of the nervous system (amyotrophic lateral 
sclerosis or multiple sclerosis) and traumatic 
spinal cord injuries shows that the same 
biomarker: pNF-H can be a lesional biomarker 
in traumatic injuries and is a reaction 
biomarker in degenerative diseases, because of 
the different pathophysiological mechanisms: 
direct injury or secondary response caused by 
other factors. 
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  A new proposed approach in spinal 
compression is based on the biomarkers as 
pNF-H; the heavy phosphorylated 
neurofilament subunit concentration can be a 
predictive lesional biomarker because the 
pattern in its values can show the reduction or 
stoppage of the secondary lesion in spinal cord 
injury with a favorable result. 
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Figure 1 - MRI of three-level disc herniation with 
cervical myelopathy: A. sagital image; 
B. normal transversal image of cervical spinal cord; C. 
transversal image of compression of cervical spinal cord 
 
The studies on biomarkers in spinal cord 
injuries highlight that the most important 
lesional biomarkers are the phosphorylated 
neurofilament subunits, light or heavy (pNF-L or 
pNF-H). The phosphorylated neurofilament 
subunits (pNF-L or pNF-H) are specific lesional 
biomarkers for spinal cord compression and 
they can distinguish the severity of SCI. The 
heavy phosphorylated neurofilament subunit 
(pNF-H) is a predictive lesional biomarker; its 
values pattern shows the reducing or stopping of 
the secondary lesions and the favorable outcome. 
There is a specific pattern of daily values of pNF-
H in complete spinal cord compression patients 
with a favorable outcome: a sudden increase up 
to a maximum value then a progressive decrease 
to normal. Also there are two patterns in the 
patients with unfavorable outcome: an increase 
to a plateau of pNF-H values or a progressive 
increase up to a peak followed by a progressive 
decrease to quasi-normal values. These specific 
patterns could be used to aid clinicians with 
making a diagnosis and establishing a prognosis, 
and evaluating therapeutic interventions.
 
 
 
 
 
 
Romanian Neurosurgery (2016) XXX 3: 317 - 320 | 319 
 
 
 
 
 
 
 
 
Figure 2 - The three specific and predictive pattern of daily values of pNF-H in traumatic SCI 
(from ref. 12) 
 
The studies on lesional biomarkers in 
spinal cord compression should continue on 
larger groups of patients to prove the clinical 
usefulness. Also the studies on reaction 
biomarkers are very important, but obtaining 
cells from the site of spinal cord compression 
is problematic in humans.  
A new approach in the management of 
acute traumatic spinal cord injury has been 
proposed that could enable obtaining cells 
from the site of spinal cord injury without 
adverse consequences for the patient. In the 
cases with a predictive pattern of unfavorable 
outcome or neurological stationary after 
decompression and stabilization during the 
first 24 hours, a new approach was proposed 
based on the predictive pattern of daily values 
of pNF-H. If the clinical neurologic evolution 
is unfavorable and imaging techniques (MRI) 
show a complete SCI and the daily values of 
pNF-H as lesional biomarker form predictive 
unfavorable pattern, a second 
microneurosurgery in the spinal cord injury 
site can create favorable conditions for 
functional recovery of the remaining spinal 
cord: opening the spinal cord in the midline 
and microsurgical debridement of the necrotic 
tissue. At the same time this second 
microneurosurgical approach in the spinal 
cord injury site could enable obtaining cells 
from this site without adverse consequences 
for the patient. The use of these cells (neurons 
and glial cells around the lesion) for cell 
culture techniques will allow the study of the 
changes in the spinal cord compression at the 
molecular and structural levels in humans.  
Diagnosis, prognosis, and treatment 
guidance based on biomarker used as a 
predictive indicator can determine ethical 
difficulties by differentiated therapies in 
patients with spinal cord compression. It is 
difficult to stop or to limit the treatment of 
neurological recovery in patients with 
complete spinal cord injury, with paraplegia or 
tetraplegia, with complete spinal cord lesions 
on imaging techniques and unfavorable 
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patterns of predictive lesional biomarkers. We 
do not currently know the value of the lesional 
predictive biomarkers, and also the reaction 
biomarkers, for the neurological outcome 
several years after the injury.  
At the moment, we cannot take a decision 
limiting the treatment of neurological 
recovery in patients with complete spinal cord 
injury because we do not know the complexity 
of the biological response to spinal cord injury. 
This requires extensive and profound research 
both on lesional biomarkers and on reaction 
biomarkers correlated with genetic and 
molecular response in spinal cord 
compression and we hope further research will 
deliver effective treatments. 
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